A tale of the epidermal growth factor receptor: The quest for structural resolution on cells
Introduction
The human epidermal growth factor receptor (hEGFR; aka HER1) is the founding member of the growth factor receptor tyrosine kinase (RTK) super-family [1]. This family also comprises 18 sub-groups of cell surface receptors for many growth factors, cytokines and hormones [2]. The evolution of the EGFR family can be traced from one receptor/ligand pair in C. elegans, through one receptor with multiple ligands in D. melanogaster, to a family comprising four receptors (HER1 and ErbB2-4, known as HER2-4 in humans) and at least 13 ligands in mammals [3], [4].
The EGFR family are key regulators of cell-to-cell inductive processes and cell fate [5]. Their function is to transmit growth factor signals from the outside to the inside of the cell where changes in gene expression allow the cell to respond to the new circumstances. Deregulated signalling by cell surface HER1 receptors (e.g. via activating mutations in the HER1 gene) is implicated in a substantial percentage of lung cancers [6]. As activation of these receptors has been shown to result in the growth and progression of the malignancy, there have been considerable research efforts directed toward the development of effective inhibitors of HER1. Several of these cancer drugs are in different stages of pre-clinical and clinical trials [7].
Here we review the efforts towards understanding the structure–function relationships underlying the transduction of the EGF signal and the activation of EGFR across the plasma membrane. This understanding requires the determination of structure at high resolution. Because biological function usually requires the interaction of many molecules within a complex system, a full understanding of the structure–function relationship is only possible if we are able to obtain structural detail of molecules within the context of their natural environment; the cell. Although this inevitably leads us to discussions of how fluorescence based microscopy techniques have been used for this purpose, we have restricted the scope of this review to efforts to elucidate EGFR macromolecular structure. For an excellent review that discusses the imaging of other aspects of EGFR biology such as interaction dynamics and the events subsequent to receptor activation please see [8]. Ultimately the goal would be to obtain atomic resolution structures from molecules in living cells, in real time, but this is likely to remain out of reach for the foreseeable future.
Section snippets
A brief history of 50+ years of EGFR biology
EGFR research can be traced back to the early 1960s, when Stanley Cohen purified the epidermal growth factor (EGF) from mouse submaxillary glands and showed that it induced precocious eyelid opening and tooth eruption in mouse embryos [9]. Given that fibroblast cells in culture responded to a treatment with 125I-labelled EGF by enhancing DNA synthesis and proliferation, Cohen and co-workers began to ask questions about how EGF induces cell growth. Initial experiments showed that EGF
Mapping the size, distribution of EGFR clusters at higher resolution
Whilst the combination of fluorescence imaging and FRET made important contributions towards our understanding of EGFR structure–function relationship, Section 3.3 illustrated that there are multiple ways to construct models of higher order oligomers from known EGFR structures that agree with the available FRET data. It is also worth noting that the expected size of EGFR oligomers (dimers >11 nm and <15 nm, tetramers >20 nm and <30 nm, etc) sits neatly in the gap between FRET which reports short
Conclusions
After nearly 5 decades of research, super-resolution fluorescence microscopy, informed by high resolution structures derived from NMR and X-ray crystallography and combined with the exploratory power of atomistic Molecular Dynamics simulations promises to deliver a deep understanding of EGFR signalling complexes in the environment of the cell membrane. As a target for anti-cancer therapies this will undoubtedly benefit our understanding of these interventions. New insights into the regulation
Acknowledgements
The authors have been funded by the Biotechnology and Biological Sciences Research Council [BB/G006911/1].
References (96)
- et al.
Cell signaling by receptor tyrosine kinases
Cell
(2010) Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal
J. Biol. Chem.
(1962)- et al.
Epidermal growth factor-receptor-protein kinase interactions. Co-purification of receptor and epidermal growth factor-enhanced phosphorylation activity
J. Biol. Chem.
(1980) - et al.
Internalization of functional epidermal growth factor receptor/kinase complexes in A-431 cells
J. Biol. Chem.
(1985) - et al.
Internalization and down-regulation of the human epidermal growth factor receptor are regulated by the carboxyl-terminal tyrosines
J. Biol. Chem.
(1991) - et al.
All autophosphorylation sites of epidermal growth factor (EGF) receptor and HER2/neu are located in their carboxyl-terminal tails. Identification of a novel site in EGF receptor
J. Biol. Chem.
(1989) - et al.
Analysis of deletions of the carboxyl terminus of the epidermal growth factor receptor reveals self-phosphorylation at tyrosine 992 and enhanced in vivo tyrosine phosphorylation of cell substrates
J. Biol. Chem.
(1990) - et al.
Self-phosphorylation enhances the protein-tyrosine kinase activity of the epidermal growth factor receptor
J. Biol. Chem.
(1985) - et al.
Detection and enumeration of transformation-defective strains of avian sarcoma virus with molecular hybridization
Virology
(1977) - et al.
EGF induces increased ligand binding affinity and dimerization of soluble epidermal growth factor (EGF) receptor extracellular domain
J. Biol. Chem.
(1991)